Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acquiesced, Adrian, Adult, agitation, Albert, antiarrhythmic, Argentina, ASU, Atlantic, Avera, AzurPharma, back, Becker, Bergen, Beth, broadly, Brunswick, callable, Ceregene, chairman, clarify, cognition, College, Columbia, constitute, contending, core, cum, customarily, demyelinating, disability, District, draft, Einstein, Elona, EMA, epilepsy, Epstein, exploiting, extremity, fellowship, fleet, founder, gene, geriatric, Green, guide, handling, headache, headcount, Hepner, hiring, Impax, incorrect, incorrectly, internationally, invoice, IVAX, Joao, King, Kogan, laude, Lhermitte, lieu, load, MAA, misinterpret, motivate, multicenter, muscle, musculoskeletal, narrowly, neuralgia, Neurontin, neuropsychiatrist, neuropsychopharmacology, neurotrophic, OPDP, optic, Ottawa, page, parallel, passage, Paulo, plasma, principle, priority, PRISM, privacy, professor, quantify, registry, Relpax, Rule, Sao, screen, secret, shape, Siffert, situated, sixty, sleep, South, Southwestern, speaking, Squibb, stay, storage, substitute, Summit, supersede, symptom, TEVA, tied, tonic, trigeminal, twenty, understood, unenforceable, unlimited, variable, vigorously, vital, widespread, withheld, Wockhardt, wording, XBRL, York
Removed:
accumulating, ACO, acyclovir, amitriptyline, antidepressant, arbitrator, attainment, bank, Biovail, byRule, called, Campho, carbamazepine, carefully, Carmex, ceased, claimed, cliff, confirmatory, contingently, coupled, Cymbalta, Denavir, Denmark, diary, disputed, divestiture, DMQ, dosed, exist, expressing, extinguishment, famciclovir, Famvir, Finland, formal, funded, genital, Herpecin, HUD, improve, improved, inRule, instituted, instrument, Intensity, jeopardize, legitimate, medicinal, MIF, narcotic, neuropathy, NIH, noncontrolling, Norway, ofAvanir, onForm, onpage, Orajel, oral, outlined, penciclovir, phenytoin, PK, pledged, powered, protocol, randomization, reacquired, redemption, relevance, relief, repayment, repeated, represented, Scandinavian, showed, significance, skincare, SPA, statistical, surrendered, Sweden, thisForm, trailing, transparency, underRule, valacyclovir, Valtrex, visit, Zenvia, Zilactin, Zovirax
Filing tables
Filing exhibits
- 10-K Annual report
- 10.24 Form of Change of Control Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
Related press release
AVNR similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the accompanying Annual Report of AVANIR Pharmaceuticals (the “Company”) on Form 10-K for the fiscal year ended September 30, 2011 (the “Report”), I, Keith A Katkin, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: December 13, 2011 | /s/ Keith A. Katkin | |||
Keith A. Katkin | ||||
President and Chief Executive Officer | ||||
[Principal Executive Officer] |